Subscribe to Newsletter

Content by Stephanie Vine:

Business & Regulation Technology and Equipment

Day 2 of Interphex

| Stephanie Vine | 2 min read

Looking for a guide to day 2 of the show? We’ve got you covered.

Discovery & Development Dosage Forms

Innovation Awards: The Grand Winner

| Stephanie Vine | 2 min read

Lonza’s Enprotect Capsule is the recipient of The Medicine Maker 2023 Innovation Awards.

Business & Regulation Technology and Equipment

Welcome to Interphex 2024!

| Stephanie Vine | 3 min read

Interphex kicks off today in New York. Here’s what to look out for on day 1.

Manufacture Advanced Medicine

Interviewing Luigi Naldini: Be a Little Different

| Stephanie Vine | 8 min read

How the drive to try something new led to the development of lentiviral vectors for gene therapy.

Business & Regulation Business Practice

Video Interview: The High Costs of Advanced Therapies, Part 2

| Stephanie Vine

Cardinal Health’s Fran Gregory looks at innovative payment models for cell and gene therapies.

Business & Regulation Business Practice

Video Interview: The High Costs of Advanced Therapies, Part 1

| Stephanie Vine

Cardinal Health’s Fran Gregory talks about the high costs of cell and gene therapies, and what this means for payers.

Business & Regulation Profession

Talent Spotting in Pharma

| Stephanie Vine | 5 min read

Have you noticed a shortage of skilled individuals entering the pharma industry?

Business & Regulation Standards & Regulation

Showdown Over the Abortion Pill in the US

| Stephanie Vine | 4 min read

The Supreme Court will decide the fate of the abortion pill mifepristone in the US on March 26, 2024.

Discovery & Development Ingredients

DEG Contamination: We Must Keep Eyes on Supply

| Stephanie Vine | 10 min read

As incidents of DEG poisoning continue to occur, the IPEC Federation issues a call for companies not to be complacent when it comes to supply chains.

Business & Regulation Business Practice

Drug Price Negotiations, Counteroffers, and Lawsuits

| Stephanie Vine | 4 min read

The US Inflation Reduction Act continues to generate controversy as drugmakers make counteroffers.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register